Products for Research Use Only
RegisterLogin

Crexavibart

CAT: 0804-HY-145641Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-145641Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Crexavibart (BMS-986413; C-144-LS) is an IgG1λ2 antibody that targets the SARS-CoV2 spike (S) glycoprotein receptor-binding domain[1].
CAS Number
2599039-61-7
Product Name Alternative
BMS-986413; C-144-LS
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/crexavibart.html
Solubility
10 mM in DMSO
Smiles
[Crexavibart]
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MBS5820322Crexavibart
GTR18399434Crexavibart Antibody
VK565266-01Research Grade Crexavibart
E55B0884Crexavibart (Reference antibody)
ICH5455-50mgCrexavibart Biosimilar - Research Grade
GTR18697220-01Crexavibart Human Monoclonal Antibody
GTR18780506-01(Crexavibart) Biosimilar Reference Antibody
A135616Crexavibart Biosimilar (Monoclonal, IgG1, lambda2)
RA0651-01Crexavibart (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)
PX-TA1829-01Crexavibart Biosimilar - Anti-SARS-CoV-2 Spike RBD mAb - Research Grade

Popular Products